Cookie Consent by Free Privacy Policy Generator Update cookies preferences

Session 12

OESO-SEMPIRE 16th World Conference | Esophagus 2024 | Strasbourg | April 23-26, 2024 | Venue: IRCAD France


<  back to Program at a glance
<  back to all the scientific sessions

 

Session 12: Interventional Endoscopy (2)

Wednesday, April 24, 4:00 – 5:30 pm
Auditorium Lindbergh

Chair: Hiroshi Mashimo (USA)

 

1) Endoscopic management of benign strictures

  1. What are various methods of dilations and considerations for optimized use? – Eric G. Sheu (USA)
  2. What are the optimal endoscopic management of refractory/recurrent stricture – Andrew Chang (USA)
  3. What radiological studies show to help guide management – Peter Pokieser (Austria)
  4. What ablation tool to chose: when and why – Roberto Trasolini (Canada)
     

2) Endoscopic management of malignant obstruction

  1. What imaging evaluations are most helpful prior to endoscopy? – Francis J. Scholz (USA)       
  2. Stents, Dilations, and Ablations: which to choose for optimal management?
  3. Are there differences in durability of endoscopic ablations comparing SCC to EAC? – Hon-Chi Yip (Hong Kong)
  4. Complications of endoscopic therapies and how to manage in setting of esophageal cancer – Michael Mwachiro (Kenya)
     

3) Endoscopic treatments of GERD

  1. What endoscopic treatments are available and how do they compare? – Wai-Kit Lo (USA)
  2. What are the roles of motility studies in optimized choice of endoscopic treatment? – Yan Jiang (USA)
  3. What is the role of endoscopic evaluation in choice of treatment? – Nicole Cherng (USA)
  4. Considerations to opt surgery over endoscopic treatments – Ann DeBord-Smith (USA)

4) Endoscopic treatments of achalasia 

  1. What radiological studies and findings are helpful in guiding mode of treatment? – Frank J. Scholz (USA)
  2. What endoscopic options do we have and critical review of manometry and anatomy in choice of therapy? – Georgios Mavrogenis (Greece)
  3. What is the evidence for and against Botox treatments? – John O. Clarke (USA) 
  4. What endoscopic assessments (careful retroflexion? FLIP?) can better guide therapy? – Salih Samo (USA)
  5. What are considerations in dealing with return of dysphagia after therapy? – Jon O. Wee (USA)
  6. What is a rational approach to selection of achalasia management – Hiroshi Mashimo (USA)